Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF506 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | GRID2IP | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | KIAA1683 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | PTCHD4 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | DPYSL2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | ZDHHC17 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | NPIPA7 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | HKR1 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | CHCHD4 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | SLC25A20 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |